Literature DB >> 16964214

Oversight of US genetic testing laboratories.

Kathy L Hudson1, Juli A Murphy, David J Kaufman, Gail H Javitt, Sara H Katsanis, Joan Scott.   

Abstract

Mesh：

Year:  2006        PMID： 16964214     DOI： 10.1038/nbt0906-1083

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  17 in total

1.  Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

2.  Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis.

Authors:  K A B Goddard; J Robitaille; N F Dowling; A R Parrado; J Fishman; L A Bradley; C A Moore; M J Khoury
Journal:  Public Health Genomics       Date:  2008-11-26       Impact factor: 2.000

3.  Pharmacogenomics, evidence, and the role of payers.

Authors:  P A Deverka
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

4.  Where medicine, business, and public policy intersect.

Authors:  Chantell L Wilson; Stephanie Schultz; Scott A Waldman
Journal:  Biotechnol Healthc       Date:  2007-02

Review 5.  Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.

Authors:  Lisa V Kalman; Ira M Lubin; Shannon Barker; Desiree du Sart; Rob Elles; Wayne W Grody; Mario Pazzagli; Sue Richards; Iris Schrijver; Barbara Zehnbauer
Journal:  Arch Pathol Lab Med       Date:  2013-07       Impact factor: 5.534

6.  A call for participatory oversight.

Authors:  Sharon F Terry
Journal:  Genet Test Mol Biomarkers       Date:  2014-02

7.  Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.

Authors:  Jennifer M Matro; Karen J Ruth; Yu-Ning Wong; Katen C McCully; Christina M Rybak; Neal J Meropol; Michael J Hall
Journal:  J Genet Couns       Date:  2014-05-06       Impact factor: 2.537

8.  Physician interpretation of variants of uncertain significance.

Authors:  Sarah K Macklin; Jessica L Jackson; Paldeep S Atwal; Stephanie L Hines
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

Review 9.  Understanding patient and provider perceptions and expectations of genomic medicine.

Authors:  Michael J Hall; Andrea D Forman; Susan V Montgomery; Kim L Rainey; Mary B Daly
Journal:  J Surg Oncol       Date:  2014-07-03       Impact factor: 3.454

10.  A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.

Authors:  Tuya Pal; Deborah Cragun; Courtney Lewis; Andrea Doty; Maria Rodriguez; Cristi Radford; Zachary Thompson; Jongphil Kim; Susan T Vadaparampil
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.